Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02707510 · ClinicalTrials.gov registry record · NA
A Trial to Strengthen Existential Resiliency Among Women With Metastatic Breast Cancer
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT02707510 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 71 participants.
The verdict
NCT02707510, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
The investigators group has piloted a 6-week psycho-educational program, Growing Resiliency And CouragE with Cancer™ (GRACE), that bring together a variety of strategies and experiences from an inter-professional perspective to mitigate distress among patients with an advanced cancer diagnosis. GRACE is a six-session, empirically anchored intervention emphasizing a Logotherapy (Existential Therapy) and Cognitive-Behavioral Therapy approach involving psycho-education and process-oriented experiences. The curriculum includes themes illustrated via PowerPoint slides with semi-structured delivery, video presentations, a variety of mindfulness meditation practices, and selected readings that serve to reflect and capture the theme for the week of the curriculum.
Interventions
- OTHER Growing Resiliency And CouragE with Cancer™ (GRACE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2016-10 |
| Est. Completion | 2020-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02707510
The ClinicalTrials.gov registry entry for NCT02707510 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Growing Resiliency And CouragE with Cancer™ (GRACE) is the first listed.
NCT02707510 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02707510 about?
NCT02707510 is a clinical study titled "A Trial to Strengthen Existential Resiliency Among Women With Metastatic Breast Cancer". The investigators group has piloted a 6-week psycho-educational program, Growing Resiliency And CouragE with Cancer™ (GRACE), that bring together a variety of strategies and experiences from an inter-professional perspective to mitigate distress among patients with an advanced cancer diagnosis. GRAC...
What is the current status of trial NCT02707510?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2016-10. Estimated completion is 2020-03.
What interventions are being tested in trial NCT02707510?
The interventions under investigation include: Growing Resiliency And CouragE with Cancer™ (GRACE) (OTHER).
Who is sponsoring clinical trial NCT02707510?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.